Protoscoleces viability was assessed microscopically by trypan blue exclusion test ( Fig. 1) . At 40 µM, artesunate and DHA exhibited similar activity as nitazoxanide (32), but the action of DHA was delayed by two days (90% viability reduction occurring on day 6.) Artemisinin and artemether were ineffective (data not shown), At 10 µM, artesunate and DHA showed strongly decreased efficacies compared to nitazoxanide (Fig. 1 ).
E. multilocularis metacestode drug assays were carried out as described (7, 9, 21, 27, 28, 30) . Artemisinins and albendazole were added to the cultures at a concentration of 40 µM. During the 12 days treatment, 200 µl of culture supernatant were collected daily and stored at -20°C to measure E. multilocularis alkaline phosphatase (EmAP) activity (30). Artesunate treatment led to a rapid increase of EmAP activity in medium supernatants within 4 days (Fig. 2 ). DHA exhibited a delayed effect, with an increased EmAP activity coming up at day 8. Artemisinin and artemether treatments did not result in a high-level EmAP release ( Treatment began at eight weeks post-infection and the drug-and controlsuspensions were applied by intra-gastric inoculation (100 µl / mouse / day) for 6 weeks. Finally, mice were sacrificed by CO 2 euthanasia, parasite tissue removed from the peritoneal cavity, and the parasite weight was determined (Fig. 3) . Parasite No adverse effects were observed in the drug-treated groups, with the exception of one mouse found dead in the DHA/albendazole-group at day 30 and one mouse in the artesunate/albendazole group found dead at day 32. These two mice could potentially be attributed to the described toxicity and neurotoxicity of artemisinin 
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